Clinical Trial Update: Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating prematuration culture with a phosphodiesterase-3 inhibitor to influence embryonic aneuploidy and developmental potential was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• cilostamide (cilostamide)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Infertility | Phase 1 | Status: TERMINATED